Your browser doesn't support javascript.
loading
Nanoparticle Mediated Tumor Vascular Disruption: A Novel Strategy in Radiation Therapy.
Kunjachan, Sijumon; Detappe, Alexandre; Kumar, Rajiv; Ireland, Thomas; Cameron, Lisa; Biancur, Douglas E; Motto-Ros, Vincent; Sancey, Lucie; Sridhar, Srinivas; Makrigiorgos, G Mike; Berbeco, Ross I.
Affiliation
  • Kunjachan S; Department of Radiation Oncology, Brigham and Women's Hospital , Dana-Farber Cancer Institute and Harvard Medical School, Boston, Massachusetts 02115, United States.
  • Detappe A; Department of Radiation Oncology, Brigham and Women's Hospital , Dana-Farber Cancer Institute and Harvard Medical School, Boston, Massachusetts 02115, United States.
  • Kumar R; Institut Lumière Matière, Université Claude Bernard Lyon1-CNRS, Université de Lyon , 69007 Lyon, France.
  • Ireland T; Department of Radiation Oncology, Brigham and Women's Hospital , Dana-Farber Cancer Institute and Harvard Medical School, Boston, Massachusetts 02115, United States.
  • Cameron L; Nanomedicine Science and Technology Center and Department of Physics, Northeastern University , Boston, Massachusetts 02115, United States.
  • Biancur DE; LA-ICP-MS and ICP-ES Laboratories, Boston University , Boston, Massachusetts 02215, United States.
  • Motto-Ros V; Department of Pediatric Oncology, Dana-Farber Cancer Institute , Boston, Massachusetts 02215, United States.
  • Sancey L; Department of Radiation Oncology, Brigham and Women's Hospital , Dana-Farber Cancer Institute and Harvard Medical School, Boston, Massachusetts 02115, United States.
  • Sridhar S; Institut Lumière Matière, Université Claude Bernard Lyon1-CNRS, Université de Lyon , 69007 Lyon, France.
  • Makrigiorgos GM; Institut Lumière Matière, Université Claude Bernard Lyon1-CNRS, Université de Lyon , 69007 Lyon, France.
  • Berbeco RI; Department of Radiation Oncology, Brigham and Women's Hospital , Dana-Farber Cancer Institute and Harvard Medical School, Boston, Massachusetts 02115, United States.
Nano Lett ; 15(11): 7488-96, 2015 Nov 11.
Article in En | MEDLINE | ID: mdl-26418302
ABSTRACT
More than 50% of all cancer patients receive radiation therapy. The clinical delivery of curative radiation dose is strictly restricted by the proximal healthy tissues. We propose a dual-targeting strategy using vessel-targeted-radiosensitizing gold nanoparticles and conformal-image guided radiation therapy to specifically amplify damage in the tumor neoendothelium. The resulting tumor vascular disruption substantially improved the therapeutic outcome and subsidized the radiation/nanoparticle toxicity, extending its utility to intransigent or nonresectable tumors that barely respond to standard therapies.
Subject(s)
Key words

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Metal Nanoparticles / Gold / Neoplasms / Neovascularization, Pathologic Limits: Humans Language: En Journal: Nano Lett Year: 2015 Document type: Article Affiliation country: United States

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Metal Nanoparticles / Gold / Neoplasms / Neovascularization, Pathologic Limits: Humans Language: En Journal: Nano Lett Year: 2015 Document type: Article Affiliation country: United States